[Clinical study of irinotecan therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer].
Nishina
Tomohiro
T
Dept. of Internal Medicine, National Hospital Organization Shikoku Cancer Center.
Hyodo
Ichinosuke
I
Moriwaki
Toshikazu
T
Kajiwara
Takeshi
T
Tsuzuki
Takao
T
Hirao
Ken
K
Tubouchi
Eiji
E
Nasu
Junichirou
J
Hirasaki
Shoji
S
Masumoto
Toshikazu
T
Kubo
Yoshiro
Y
Kurita
Akira
A
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D011743:Pyrimidines / Q000494:pharmacology; D012189:Retrospective Studies; D015996:Survival Rate
D011743:Pyrimidines; D016685:Mitomycin; D000077146:Irinotecan; D002166:Camptothecin